The only CRO specialized in full human immune system mouse disease models for Cancer, Infectious, Inflammation and Vaccines.
TransCure bioServices is a CRO providing in vivo pharmacology preclinical services with unique Research & Development (R&D) and fee-for-service platforms, called the Full Human Immune System Mouse (hu-mouse) Models.
Customers access these full services (protocol design, raw data collection, analysis, reports) in our BSL-2 and BSL-3 animal and laboratory technology (flow cytometry, cell biology) facilities on a very attractive fee-for-service basis.
Highest needs for large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases such as inflammation, cancer, or infectious diseases. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.
Why choosing us?
TransCure bioServices offers a unique service! We are proactive and your trustworthy partner!
TransCure bioServices provides state-of-the-art disease models for cancer, PDX, inflammation, infectious and vaccine indications, develops regularly new models, has a high specialization, creates a unique relationship with its customers, delivers speedy results without overlooking the quality and offers those all advantages at a highly competitive FTE rate. We are a flexible team and data driven.
The CRO you need
TransCure is a specialized company with a human scale service platform. The highest quality of our relationship with our customers is a key ingredient and an indisputable advantage to offer you our services which are always adapted to your needs. We make our client our first choice! You remain the Sponsor of course.
We apply the strictest regulation in compliance with the national laws of EUROPE, and France in particular, guidelines and regulations to underpin our own global bioethical chart: 3Rs commitment & highest standards of care and ethics.
High quality standards
We have started in 2018 the AAALAC accreditation/validation process and have successfully been audited by several large pharma and biotechnology companies since company inception.
Save time and budget; Focus on the most promising clinical candidates; full human immune system mouse model data are useful for IND filling; We are a One Stop Shop for in vivo pharmacology preclinical expertise; non-GLP; Flexible and highly Adaptable; Competitive FTE Rate
TransCure bioServices is a dynamic CRO which regularly creates new DATA and models. Find out our news and discover more about our recognized expertise for in vivo pharmacology.
What services TransCure bioServices is offering? Who are its clients? What are its achievements? What are its news goals and new challenges with its recent funding of 2.5 million euros? Get the answers in the ECO article. (article n french).
New financing round will enable the company to accelerate its growth and expand its international services offers.
Strategic partnership with Champions Oncology, Inc
TransCure bioServices SAS was selected for the SME instruments call-to-offer Phase 1 with 273 companies out of 2’822 applicants.
TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer
INSERM publishes first in vivo proof of concept of an engineered Chimeric Antigen Receptor T cell directed against IL-1RAP expressed by leukemia stem cells using TransCure’s full human immune system hu-mouse models.
7TH AIS 2019...
AFSSI Connexions 2019...
NLS DAYS 2019...
Malmö – SWEDEN
Next Gen Immuno-Oncology Congr...